These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 8294874)

  • 21. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells.
    Bix M; Raulet D
    J Exp Med; 1992 Sep; 176(3):829-34. PubMed ID: 1512546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
    Schulz R; Mellor AL
    J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.
    Taylor SF; Bender BS
    Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.
    Höglund P; Ohlén C; Carbone E; Franksson L; Ljunggren HG; Latour A; Koller B; Kärre K
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10332-6. PubMed ID: 1946452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of CD8 alpha alpha+ intestinal intraepithelial T cells in beta 2-microglobulin- and/or TAP1-deficient mice.
    Fujiura Y; Kawaguchi M; Kondo Y; Obana S; Yamamoto H; Nanno M; Ishikawa H
    J Immunol; 1996 Apr; 156(8):2710-5. PubMed ID: 8609387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.
    Huang R; Guo J; Li X; Faustman DL
    Diabetes; 1995 Sep; 44(9):1114-20. PubMed ID: 7657037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
    J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restricted recognition of beta 2-microglobulin by cytotoxic T lymphocytes.
    Rammensee HG; Robinson PJ; Crisanti A; Bevan MJ
    Nature; 1986 Feb 6-12; 319(6053):502-4. PubMed ID: 3511388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells.
    Quinn DG; Zajac AJ; Frelinger JA; Muller D
    Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.
    Sandberg JK; Chambers BJ; Van Kaer L; Kärre K; Ljunggren HG
    Eur J Immunol; 1996 Feb; 26(2):288-93. PubMed ID: 8617293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.
    Koller BH; Marrack P; Kappler JW; Smithies O
    Science; 1990 Jun; 248(4960):1227-30. PubMed ID: 2112266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes.
    Schell TD; Mylin LM; Tevethia SS; Joyce S
    Int Immunol; 2002 Jul; 14(7):775-82. PubMed ID: 12096037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice.
    Marusić-Galesić S; Udaka K; Walden P
    Eur J Immunol; 1993 Dec; 23(12):3115-9. PubMed ID: 8258325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.
    Denkers EY; Gazzinelli RT; Martin D; Sher A
    J Exp Med; 1993 Nov; 178(5):1465-72. PubMed ID: 8228800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.